Anti-HCV Selective High Affinity Ligands to Block HCV E2-CD81 Interaction
New compounds that block Hepatitis C virus from entering the cell and possibly reduce the potential inflammation and other pathologies.
Published: 8th May 2019

Patents
- WO2015128744A2
IP Status
- Patent application submitted